Background: Evidence that antenatal administration of magnesium sulfate (MgSO4) to women in preterm labor may confer fetal neuroprotection is growing. MgSO4 crosses the placenta and can affect the neonate. Magnesium homeostasis in extremely low birth weight (ELBW) infants remains to be clarified. Objectives: We aimed to assess the natural progression of serum magnesium (Mg) in ELBW infants not exposed to antenatal MgSO4 during the first month of life. Methods: Laboratory data of a group of ELBW infants born in a tertiary center over a 1-year period were analyzed. Serum Mg was recorded daily for the first week and thereafter each week for a month for each infant. Concurrent calcium, phosphate and alkaline phosphatase were measured. Results: 51 preterm infants (24 female) with a birth weight <1,000 g were included (33 were born at <27 weeks’ gestation). The mean magnesium ranged from 0.9 to 1.1 mmol/l over the first week with a minimum of 0.62 mmol/l and maximum of 1.53 mmol/l. Mg rises in the first few days before stabilizing and remains within a narrow range thereafter. Conclusions: In ELBW infants, Mg tends to rise initially then stabilize and remain normal thereafter. The effect of antenatal MgSO4 on magnesium homeostasis requires further study.

Keywords:
Magnesium, Infant, Extremely low birth weight, Magnesium sulfate, Calcium, Phosphate, Alkaline phosphatase
This content is only available via PDF.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.